Today’s important news reports address:
- 5- and 7-year survival data following iodine-125 permanent implant brachytherapy
- Risks associated with low levels of lymphocyte apoptosis in patients receiving radiation therapy
- Stiffening of the large arteries in men receiving antiandrogen therapy
- The status of the toremifene and denosumab applications for approval for marketing in the USA … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: antiandrogen, apoptosis, approval, arteries, brachytherapy, denosumab, iodine-125, long-term, lymphocyte, radiation therapy, stiffening, survival, toremifene, toxicity | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 